Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Alimera Resubmits Iluvien In U.S. As It Begins EU Launch

Related Content

FDA Issues "Complete Response" On Alimera's Iluvien; Eyes More Data

Dec 30 2010

U.K. Cost Watchdog Rejects Lucentis’ Extended Use In Eye Disease

Nov 24 2011

Alimera To Resubmit <em>Iluvien</em> With No New Studies

Sep 28 2012

Related Companies

Alimera Sciences Inc.

Roche Holding AG

Genentech, Inc.

Additional Topics

Business Strategies Launches BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window